Krispy Kreme Adopts Poison Pill to Ward Off Potential

Krispy Kreme Doughnuts Inc., whose shares have jumped this year amid speculation it’s an acquisition target, adopted measures to discourage investors from buying 5 percent or more of the company’s stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.